Shares of Pediatrix Medical Group (MD) plummeted 5.25% in Friday's intraday trading session, underperforming the broader market.
The decline in Pediatrix Medical's stock price appears to be driven by multiple analysts lowering their price targets for the company. Truist Securities adjusted its price target for MD from $15 to $18, maintaining a Hold rating. Similarly, Deutsche Bank lowered its target price from $15 to $17 while keeping a Hold rating.
Despite the downward revisions, analysts polled by FactSet still maintain an average overweight rating on Pediatrix Medical with a mean price target of $17.93, indicating potential for upside from the current stock levels.